ArticleExploration of targeted anti-tumor therapy2022

Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model.

Kate M Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.